{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:19:24Z","timestamp":1788970764982,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jaip.2025.07.008","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:31:17Z","timestamp":1752679877000},"page":"2229-2241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Evaluation and Outcome Measures of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria"],"prefix":"10.1016","volume":"13","author":[{"given":"Karsten","family":"Weller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrashis","family":"Podder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andac","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Gimenez-Arnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Neisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Altrichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.07.008_bib1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA(2)LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/all.14037","article-title":"Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis","volume":"75","author":"Fricke","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2340\/00015555-2941","article-title":"Clinical features of chronic spontaneous urticaria that predict disease prognosis and refractoriness to standard treatment","volume":"98","author":"Curto-Barredo","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2025.07.008_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-022-00389-z","article-title":"Urticaria","volume":"8","author":"Kolkhir","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaip.2025.07.008_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/bjd.19561","article-title":"The global burden of chronic urticaria for the patient and society","volume":"184","author":"Goncalo","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.07.008_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1684\/ejd.2024.4600","article-title":"Biomarkers to predict therapeutic response in chronic spontaneous urticaria: a review","volume":"34","author":"Gimenez-Arnau","year":"2024","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaip.2025.07.008_bib7","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.jaip.2023.05.033","article-title":"Association between serum total IgE levels and clinical response to omalizumab for chronic spontaneous urticaria: a systematic review and meta-analysis","volume":"11","author":"Chuang","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.008_bib8","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.jaci.2018.02.021","article-title":"Basophil FcvarepsilonRI expression is linked to time to omalizumab response in chronic spontaneous urticaria","volume":"141","author":"Deza","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.008_bib9","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jaip.2019.01.026","article-title":"Relevance of the basophil high-affinity IgE receptor in chronic urticaria: clinical experience from a tertiary care institution","volume":"7","author":"Deza","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.008_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12117","article-title":"IgE and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance","volume":"12","author":"Gimenez-Arnau","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib11","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1111\/all.13586","article-title":"Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab","volume":"73","author":"Weller","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib12","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4168\/aair.2019.11.5.736","article-title":"Factors predicting the response to cyclosporin treatment in patients with chronic spontaneous urticaria: a systematic review","volume":"11","author":"Kulthanan","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"issue":"Suppl 3","key":"10.1016\/j.jaip.2025.07.008_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jdv.13200","article-title":"Chronic urticaria: tools to aid the diagnosis and assessment of disease status in daily practice","volume":"29","author":"Weller","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.07.008_bib14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/jdv.14221","article-title":"Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria","volume":"31","author":"Sanchez-Borges","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.07.008_bib15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jaip.2021.10.012","article-title":"Prevalence, management, and anaphylaxis risk of cold urticaria: a systematic review and meta-analysis","volume":"10","author":"Prosty","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.008_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jaip.2015.09.021","article-title":"Cholinergic urticaria with anaphylaxis: an underrecognized clinical entity","volume":"4","author":"Vadas","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.008_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.808543","article-title":"Differential diagnosis of urticarial lesions","volume":"3","author":"Matos","year":"2022","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.anai.2024.10.026","article-title":"Endotypes, phenotypes, and biomarkers in chronic spontaneous urticaria: evolving toward personalized medicine","volume":"134","author":"Lang","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.07.008_bib19","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jaip.2022.11.016","article-title":"The benefit of complete response to treatment in patients with chronic spontaneous urticaria-CURE results","volume":"11","author":"Kolkhir","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.008_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.iac.2016.08.005","article-title":"Clinical measures of chronic urticaria","volume":"37","author":"Weller","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2025.07.008_bib21","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.jaip.2024.08.021","article-title":"Patient-reported outcome measures in chronic spontaneous urticaria, angioedema, and atopic dermatitis","volume":"12","author":"Bernstein","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.008_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/JAA.S91505","article-title":"Aquagenic urticaria: diagnostic and management challenges","volume":"9","author":"Rothbaum","year":"2016","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.23822\/EurAnnACI.1764-1489.343","article-title":"Salt dependent aquagenic urticaria: nine new cases and proposal for a diagnostic work-up","volume":"56","author":"Gallo","year":"2024","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.008_bib24","doi-asserted-by":"crossref","DOI":"10.23822\/EurAnnACI.1764-1489.381","article-title":"Provocation test on stairs: a new accessible method to cholinergic urticaria diagnosis","author":"Azizi","year":"2025","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.008_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2133.1978.tb07332.x","article-title":"Tests to establish the diagnosis in cholinergic urticaria","volume":"98","author":"Commens","year":"1978","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.07.008_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1365-2230.2001.00780.x","article-title":"Contact urticaria","volume":"26","author":"Wakelin","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2025.07.008_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12016-018-8687-y","article-title":"Food-related contact dermatitis, contact urticaria, and atopy patch test with food","volume":"56","author":"Walter","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.07.008_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2133.1989.tb04167.x","article-title":"Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine","volume":"120","author":"Lawlor","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.07.008_bib29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/ced.12107","article-title":"A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism","volume":"38","author":"Mlynek","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2025.07.008_bib30","doi-asserted-by":"crossref","first-page":"T357","DOI":"10.1016\/j.ad.2025.02.010","article-title":"[Translated article] Erythema, localized edema and heat vs forearm perimeter increase. Time to revise the consensus recommendations on the vortex provocation test in vibratory urticaria-angioedema?","volume":"116","author":"Gatica-Ortega","year":"2025","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaip.2025.07.008_bib31","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/all.12884","article-title":"The definition, diagnostic testing, and management of chronic inducible urticarias\u2014the EAACI\/GA(2) LEN\/EDF\/UNEV consensus recommendations 2016 update and revision","volume":"71","author":"Magerl","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jaip.2023.11.029","article-title":"Comorbid inducible urticaria is linked to non-autoimmune chronic spontaneous urticaria: CURE insights","volume":"12","author":"Kovalkova","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.008_bib33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jdv.19637","article-title":"A comparative analysis of chronic inducible urticaria in 423 patients: clinical and laboratory features and comorbid conditions","volume":"38","author":"Ornek","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.07.008_bib34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2133.1988.tb02562.x","article-title":"Combined cold urticaria and cholinergic urticaria\u2014clinical characterization and laboratory findings","volume":"118","author":"Ormerod","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.07.008_bib35","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/jdv.12739","article-title":"An improved Peltier effect-based instrument for critical temperature threshold measurement in cold- and heat-induced urticaria","volume":"29","author":"Magerl","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.07.008_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/ced.12547","article-title":"Validation of a simplified provocation instrument for diagnosis and threshold testing of symptomatic dermographism","volume":"40","author":"Schoepke","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2025.07.008_bib37","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1398-9995.2005.00833.x","article-title":"A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL)","volume":"60","author":"Baiardini","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaip.2024.10.011","article-title":"Validation of the Cholinergic Urticaria Activity Score (CholUAS)","volume":"13","author":"Schnarkowski","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.008_bib39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/cea.13102","article-title":"Development and validation of the Cholinergic Urticaria Quality-of-Life Questionnaire (CholU-QoL)","volume":"48","author":"Ruft","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib40","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/ACI.0000000000000163","article-title":"Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema","volume":"15","author":"Weller","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.008_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/all.13271","article-title":"Comparison and interpretability of the available urticaria activity scores","volume":"73","author":"Hawro","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib42","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/bjd.15454","article-title":"Analysis of disease activity categories in chronic spontaneous\/idiopathic urticaria","volume":"177","author":"Stull","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.07.008_bib43","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jaip.2017.10.001","article-title":"The urticaria activity score-validity, reliability, and responsiveness","volume":"6","author":"Hawro","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.008_bib44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2500\/aap.2015.36.3873","article-title":"The minimal important difference for measures of urticaria disease activity: updated findings","volume":"36","author":"Mathias","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2025.07.008_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.anai.2011.09.008","article-title":"Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria","volume":"108","author":"Mathias","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.07.008_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40257-017-0331-8","article-title":"Comparison of Urticaria Activity Score over 7 days (UAS7) values obtained from once-daily and twice-daily versions: results from the ASSURE-CSU study","volume":"19","author":"Hollis","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaip.2025.07.008_bib47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000507218","article-title":"Urticaria: Collegium Internationale Allergologicum (CIA) update 2020","volume":"181","author":"Maurer","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.07.008_bib48","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/all.12209","article-title":"Development, validation, and initial results of the Angioedema Activity Score","volume":"68","author":"Weller","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib49","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.jaci.2016.05.026","article-title":"Antihistamine updosing reduces disease activity in patients with difficult-to-treat cholinergic urticaria","volume":"138","author":"Koch","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.008_bib50","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1111\/all.15310","article-title":"Development of the Cold Urticaria Activity Score","volume":"77","author":"Ahsan","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2025.04.012","article-title":"Validation of the Urticaria Activity Score for Cold Urticaria","author":"Grekowitz","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.008_bib52","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jaci.2013.12.1076","article-title":"Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control","volume":"133","author":"Weller","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.008_bib53","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.jaci.2017.04.050","article-title":"Responsiveness and minimal important difference of the urticaria control test","volume":"140","author":"Ohanyan","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.008_bib54","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jaci.2023.03.034","article-title":"The 7-day recall period version of the Urticaria Control Test-UCT7","volume":"152","author":"Buttgereit","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.008_bib55","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/all.14144","article-title":"Development of the Angioedema Control Test\u2014a patient-reported outcome measure that assesses disease control in patients with recurrent angioedema","volume":"75","author":"Weller","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib56","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jaip.2020.02.038","article-title":"Validation of the Angioedema Control Test (AECT)\u2014a patient-reported outcome instrument for assessing angioedema control","volume":"8","author":"Weller","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.008_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12295","article-title":"Sensitivity to change and minimal clinically important difference of the angioedema control test","volume":"13","author":"Fijen","year":"2023","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib58","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1398-9995.2008.01920.x","article-title":"The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings","volume":"64","author":"Mlynek","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib59","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1111\/all.13939","article-title":"Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL)","volume":"74","author":"Baiardini","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib60","first-page":"137","article-title":"Minimal clinical important difference (MCID) of the Thai Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL)","volume":"34","author":"Kulthanan","year":"2016","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.07.008_bib61","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/all.12007","article-title":"Development and construct validation of the angioedema quality of life questionnaire","volume":"67","author":"Weller","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib62","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/all.12900","article-title":"The Angioedema Quality of Life Questionnaire (AE-QoL)\u2014assessment of sensitivity to change and minimal clinically important difference","volume":"71","author":"Weller","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib63","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12955-019-1229-3","article-title":"Angioedema quality of life questionnaire (AE-QoL)\u2014interpretability and sensitivity to change","volume":"17","author":"Kulthanan","year":"2019","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jaip.2025.07.008_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.70038","article-title":"Development of the symptomatic dermographism quality of life questionnaire","volume":"15","author":"Munoz","year":"2025","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib65","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/all.13209","article-title":"The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU","volume":"72","author":"Maurer","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12089","article-title":"Chronic urticaria patients are interested in apps to monitor their disease activity and control: a UCARE CURICT analysis","volume":"11","author":"Cherrez-Ojeda","year":"2021","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib67","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1111\/all.15061","article-title":"Automatic screening of self-evaluation apps for urticaria and angioedema shows a high unmet need","volume":"76","author":"Anto","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12328","article-title":"CRUSE\u00ae\u2014an innovative mobile application for patient monitoring and management in chronic spontaneous urticaria","volume":"14","author":"Neisinger","year":"2024","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib69","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/all.16371","article-title":"Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: a CRUSE(R) mobile health study","volume":"80","author":"Sousa-Pinto","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.008_bib70","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jaip.2024.03.050","article-title":"Patient-reported outcome measures in atopic dermatitis and chronic urticaria are underused in clinical practice","volume":"12","author":"Cherrez-Ojeda","year":"2024","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825006415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825006415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:01:17Z","timestamp":1757775677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825006415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2213219825006415"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.07.008","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Evaluation and Outcome Measures of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}